We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)

Abbott Diagnostics (Lake Bluff, IL, USA) displayed its leading-edge technology at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo with demonstrations of its innovative systems, automation and informatics.

Abbott’s innovative solutions on display at AACC 2021 included Alinity Systems, total laboratory automation and AliniQ Informatics and Professional Services. The company also showed how labs can create an agile strategy with The Abbott Transformation System and the invaluable answers that it placed in the hands of doctors, clinicians and caregivers at the Point of Care.

Abbott’s Alinity family comprises next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics. On display at the event were the Alinity ci-series integrated clinical chemistry & immunoassay system, Alinity c clinical chemistry system, ALINITY I immunoassay system, and the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer. Each Alinity system includes a number of features to help institutions, clinicians and laboratorians better navigate through a pressure-packed health care environment. Designed with universal, intuitive interfaces as well as common software and hardware, Abbott's Alinity systems have the ability to work together, providing greater capacity and simplifying the user experience. Several of the platforms are designed to run more tests in less space, generate test results faster and minimize human errors.

At AACC 2021, Abbott also highlighted its synergistic suite of automation and high volume end-to-end solutions that deliver seamless productivity across the entire laboratory. This included the ACCELERATOR a3600 total laboratory automation system that provides the power and flexibility to meet the needs of the laboratory, both today and in the future. Combined with informatics and lean principles, the ACCELERATOR a3600 maximizes efficiency by providing consistent, predictable sample management and helps improve patient care by minimizing opportunities for error.

Additionally, Abbott demonstrated how its AlinIQ suite of professional services can help labs uncover intelligent insights from their laboratory data and discover greater operational productivity with existing resources. For instance, Abbott’s The AlinIQ Always On services deliver predictive alerts to labs, enabling the detection and prevention of instrument downtime up to three days in advance. The AlinIQ AMS (Analyzer Management System) provides labs and hospital networks the ability to integrate different software systems into a single standardized platform to optimize sample processing time, workflow efficiency and quality results. Similarly, the AlinIQ BIS (Business Intelligence System) provides the tools to optimize throughput and capacity of existing systems to help labs absorb volume increases without additional budget. By delivering intelligent insights, AlinIQ BIS helps labs improve operations and operational expense performance and communicate the lab's value to the broader health care organization. The AlinIQ IMS (Inventory Management System), which combines innovative RFID technology and streamlined process consulting, allows labs to get ahead of operational needs, helping avoid shortages of critical items, reduce waste and time taken for manual processes.

Related Links:
Abbott Diagnostics

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics